newsfilter
← Latest News
Business Wire·

Bernstein Liebhard LLP Announces Investigation of Offer for ISTA Pharmaceuticals, Inc.

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard LLP is investigating whether the Board of Directors of ISTA Pharmaceuticals, Inc. (“ISTA” or the “Company”) (Nasdaq: ISTA) is breaching its fiduciary duty to its shareholders in failing to embrace premium offers for the company by Valeant Pharmaceuticals International, Inc. (“Valeant Pharmaceuticals”).